Federal award (DEFINITIVE CONTRACT, fiscal year 2023)
Recipient: SCANDINAVIAN BIOPHARMA HOLDING AB
Awarding agency: Department of Defense / Defense Health Agency
Funding agency: Department of Defense / Defense Health Agency
Period of performance: 2020-09-25 to 2024-09-25
Current total value of award: $51057681.78
Description: THIS CONTRACT IS FOR THE DEVELOPMENT OF AN E. COLI VACCINE FOR FDA APPROVAL.